Compare SATL & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SATL | BVS |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | 154 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.5M | 617.1M |
| IPO Year | N/A | 2016 |
| Metric | SATL | BVS |
|---|---|---|
| Price | $7.37 | $9.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $5.50 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 14.4M | 410.7K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $85.89 | $7.52 |
| Revenue Next Year | $57.22 | $7.06 |
| P/E Ratio | ★ N/A | $28.56 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.26 | $5.81 |
| 52 Week High | $8.02 | $9.53 |
| Indicator | SATL | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 72.17 | 69.02 |
| Support Level | $3.18 | $8.43 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.99 | 0.35 |
| MACD | 0.13 | 0.05 |
| Stochastic Oscillator | 80.83 | 100.00 |
Satellogic Inc is a vertically integrated Earth observation company that designs, manufactures, and operates satellite systems, delivering decision-grade insights at scale to government and commercial customers. Through an end-to-end production and operations model, it provides governments with flexible options across their journey toward sovereign Earth observation. From access to high-frequency imagery and managed space systems to full satellite ownership, to supporting autonomous data availability and long-term technological independence. It has monitoring and alert-driven workflows that help defense and intelligence agencies, civil governments, and commercial operators transition from reactive tasking to proactive decision-making, providing mission-critical data when needed.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.